Received May 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y011215 | — |
No additional AE reported; PROQUAD that experienced temperature excursion was administered to one patient; This spontaneous report was received from a/an Consumer or other non health professional and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 10-Apr-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), lot #Y011215, expiration date: 18-Dec-2025, administered for prophylaxis (strength, dose and route of administration were not reported) following temperature excursion occurred in February 2025 (Temperature 6°F to 14°F (7.2F) for 0 hours 20 minutes 0 seconds) (Improper storage of product in use). The vaccine was reconstituted with sterile diluent. No previous temperature excursion. No additional details provided. No additional AE reported (No adverse event).
Sterile diluent